ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.14079
0.08%
Brent Oil
84.345
0.19%
Bitcoin
62,011.96
0.34%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nyxoah SA (NYXH)

  7. Nyxoah SA (NYXH) Noticias

NYXH Nyxoah SA

7.9475
-0.0025 (-0.03%)
25 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nyxoah SA NYXH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0025 -0.03% 7.9475 15:08:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.63 7.5001 8.00 7.9475 7.95
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202415:30GLOBENyxoah to Participate in the Jefferies Global Healthcare..
03/6/202415:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202415:15GLOBEInformation on the total number of voting rights and shares
03/6/202415:05GLOBEPublication relating to transparency notifications
31/5/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202401:00GLOBENyxoah Announces Closing of Offering and Partial Exercise of..
30/5/202416:20EDGAR2Form SC 13D/A - General statement of acquisition of..
29/5/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202415:30GLOBEInformation on the Total Number of Voting Rights and Shares
24/5/202415:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202415:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/5/202408:59GLOBENyxoah Announces Pricing of Offering
22/5/202415:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/5/202415:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/5/202415:10GLOBENyxoah Announces Reduction of the Maximum Amount Available..
22/5/202415:05GLOBENyxoah Announces Proposed Offering of Ordinary Shares
14/5/202415:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202415:05GLOBENyxoah Reports First Quarter 2024 Financial and Operating..
13/5/202415:30GLOBENyxoah to Release First Quarter 2024 Financial Results on..
10/5/202400:00GLOBEInvitation to attend the annual and the extraordinary..
11/4/202415:30GLOBENyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical..
29/3/202415:30GLOBEInformation on the total number of voting rights and shares
25/3/202401:05GLOBENyxoah Advances Patient Access Strategy through Partnership..
19/3/202415:05GLOBENyxoah Announces DREAM U.S. Pivotal Study Meets Primary..
05/3/202415:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202415:05GLOBENyxoah Reports Fourth Quarter and Financial Year 2023..
29/2/202415:30GLOBENyxoah to Participate in the Oppenheimer 34th Annual..
15/2/202415:30GLOBENyxoah to Release Fourth Quarter and Financial Year 2023..
14/2/202415:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202415:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202415:05GLOBENyxoah Announces 2024 Strategic Priorities
09/1/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202415:05GLOBENyxoah Announces Preliminary Results for the Fourth Quarter..
11/12/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202300:30GLOBENyxoah Announces Real World Case Series Demonstrating..
08/12/202315:30GLOBEPublication Relating to a Transparency Notification
28/11/202315:30GLOBENyxoah Strengthens its Executive Leadership Team
21/11/202315:30GLOBENyxoah to Participate in the Piper Sandler 35th Annual..
08/11/202315:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202315:05GLOBENyxoah Reports Third Quarter 2023 Financial and Operating..
07/11/202315:30GLOBENyxoah to Participate in the Jefferies London Healthcare..
26/10/202315:30GLOBENyxoah to Release Third Quarter 2023 Financial Results on..
29/9/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202315:30GLOBENyxoah Announces Partnership with ResMed in Germany
12/9/202315:30GLOBENyxoah to Participate in the Cantor Fitzgerald Global..
05/9/202315:30GLOBENyxoah to Participate in Upcoming Investor Conferences
30/8/202315:30GLOBEInformation on the Total Number of Voting Rights and Shares
08/8/202315:05GLOBENyxoah Reports Second Quarter and First Half 2023 Financial..
28/7/202314:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202315:30GLOBENyxoah to Release Second Quarter 2023 Financial Results on..

Su Consulta Reciente

NASDAQ
NYXH
Nyxoah
BIT
P21N79
NLBNPIT21N79 20351221 10...
LSE
SDX
Sdx Energy
NYSE
NZT
Telecom NZ
EU
BNPEX
BNP Paribas 1.375% Coupo...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados